SOMX, Somaxon Pharmaceuticals, Inc. ** Pernix Therapeutics Holdings, Inc. and SOMX reported that they have entered into a definitive merger agreement for Pernix to acquire SOMX in a stock-for-stock transaction with a total equity value of $25 million.Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, SOMX stockholders will receive aggregate consideration equal to $25 million in Pernix common stock.
SOMX is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area.More about SOMX at
www.somaxon.com ******************************** Read Full Disclaimer at
http://pennyomega.com/disclaimer http://pennyomega.com/26561/stock-alerts/pernix-therapeutics-to-acquire-somaxon-pharmaceuticals-somx-in-a-25m-stock-for-stock-transaction/